Because this study was a cross-sectional study, we measured serum VEGF levels at the same time in AD patients with depression and a longitudinal study is needed to compare VEGF levels with improvements in depressive symptoms to demonstrate the effectiveness of VEGF as a prognostic factor. The gene discussed is VEGFA; the disease is major depressive disorder.